DCPH — Deciphera Pharmaceuticals Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Deciphera Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-192	-266	-300	-179	-195
Depreciation
Deferred Taxes
Non-Cash Items	17.4	38.4	55.3	54.8	47.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital	24.8	-13.9	0.82	-32.4	-1.54
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	-149	-240	-241	-153	-147
Capital Expenditures	-4.93	-5.32	-5.97	-0.841	-0.778
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-456	33.8	183	-33.5	13.3
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities	-461	28.5	177	-34.3	12.5
Financing Cash Flow Items	-0.62	-0.815	-0.04	-0.425	-0.634
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	436	227	14.9	165	152
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-173	15.6	-48.8	-22.3	18.8